Neuberger Berman Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Neuberger Berman Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,949	Closed	-$2.24M	–	1683
2015 Q1	$2.24M	Sell	12,949 -302,053	-96%	-$44.3M	﹤0.01%	1060
2014 Q4	$36.2M	Buy	315,002 +191,256	+155%	+$23.2M	0.04%	495
2014 Q3	$19.3M	Buy	+123,746	New	+$17.9M	0.02%	688

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Neuberger Berman Group's SLXP Position: Q2 2015 in Review

Neuberger Berman Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 12,949 shares — an estimated $2.24M sold.

Neuberger Berman Group first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $36.2M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Neuberger Berman Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Neuberger Berman Group sold 12,949 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.24M.
Neuberger Berman Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
Neuberger Berman Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $36.2M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Neuberger Berman Group's 13F filing for Q2 2015, filed 31 Jul 2015.